The U.S. Is Running Out Of A Critical Childhood Cancer Drug And There Is No Suitable Replacement.

Supplies of vincristine, a crucial drug in the treatment of several childhood cancers, are running critically low after one of the two manufacturers of the drug ceased production in July.